• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睡茄内酯a诱导乳腺癌细胞中乳腺癌易感基因1和热休克因子1蛋白的蛋白酶体依赖性降解。

Withaferin a induces proteasome-dependent degradation of breast cancer susceptibility gene 1 and heat shock factor 1 proteins in breast cancer cells.

作者信息

Zhang Xuan, Timmermann Barbara, Samadi Abbas K, Cohen Mark S

机构信息

Department of Surgery, University of Kansas School of Medicine, Kansas City, KS 66160, USA.

Department of Medicinal Chemistry, The University of Kansas, Lawrence, KS 66045, USA.

出版信息

ISRN Biochem. 2012 Sep 1;2012:707586. doi: 10.5402/2012/707586. eCollection 2012.

DOI:10.5402/2012/707586
PMID:25969759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4392979/
Abstract

The purpose of this study was to examine the regulation of prosurvival factors heat shock factor 1 (HSF1) and breast cancer susceptibility gene 1 (BRCA1) by a natural withanolide withaferin A (WA) in triple negative breast cancer cell lines MDA-MB-231 and BT20. Western analysis was used to examine alternations in HSF1 and BRCA1 protein levels following WA treatment. A protein synthesis inhibitor cycloheximide and a proteasome inhibitor MG132 were used to investigate the mechanisms of HSF1 and BRCA1 regulation by WA. It was found that WA induced a dose-dependent decrease in HSF1 and BRCA1 protein levels. Further analysis showed that levels of HSF1 and BRCA1 proteins decreased rapidly after WA treatment, and this was attributed to WA-induced denaturation of HSF1 and BRCA1 proteins and subsequent degradation via proteasome-dependent, and protein-synthesis dependent mechanism. In summary, WA induces denaturation and proteasomal degradation of HSF1 and BRCA1 proteins. Further studies are warranted to examine the contribution of HSF1 and BRCA1 depletion to the anticancer effects of WA in breast cancer.

摘要

本研究的目的是检测天然睡茄内酯类化合物印度辣木宁A(WA)对三阴性乳腺癌细胞系MDA-MB-231和BT20中生存促进因子热休克因子1(HSF1)和乳腺癌易感基因1(BRCA1)的调控作用。采用蛋白质免疫印迹分析检测WA处理后HSF1和BRCA1蛋白水平的变化。使用蛋白质合成抑制剂放线菌酮和蛋白酶体抑制剂MG132来研究WA对HSF1和BRCA1的调控机制。结果发现,WA可诱导HSF1和BRCA1蛋白水平呈剂量依赖性降低。进一步分析表明,WA处理后HSF1和BRCA1蛋白水平迅速下降,这归因于WA诱导的HSF1和BRCA1蛋白变性,随后通过蛋白酶体依赖性和蛋白质合成依赖性机制降解。总之,WA可诱导HSF1和BRCA1蛋白变性和蛋白酶体降解。有必要进一步研究HSF1和BRCA1缺失对WA在乳腺癌中的抗癌作用的贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbf/4392979/6e8006d91f30/ISRN.BIOCHEMISTRY2012-707586.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbf/4392979/f633beba899e/ISRN.BIOCHEMISTRY2012-707586.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbf/4392979/17c141c7a68f/ISRN.BIOCHEMISTRY2012-707586.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbf/4392979/359eac24923d/ISRN.BIOCHEMISTRY2012-707586.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbf/4392979/5fb98c718fdd/ISRN.BIOCHEMISTRY2012-707586.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbf/4392979/6e8006d91f30/ISRN.BIOCHEMISTRY2012-707586.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbf/4392979/f633beba899e/ISRN.BIOCHEMISTRY2012-707586.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbf/4392979/17c141c7a68f/ISRN.BIOCHEMISTRY2012-707586.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbf/4392979/359eac24923d/ISRN.BIOCHEMISTRY2012-707586.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbf/4392979/5fb98c718fdd/ISRN.BIOCHEMISTRY2012-707586.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dbf/4392979/6e8006d91f30/ISRN.BIOCHEMISTRY2012-707586.005.jpg

相似文献

1
Withaferin a induces proteasome-dependent degradation of breast cancer susceptibility gene 1 and heat shock factor 1 proteins in breast cancer cells.睡茄内酯a诱导乳腺癌细胞中乳腺癌易感基因1和热休克因子1蛋白的蛋白酶体依赖性降解。
ISRN Biochem. 2012 Sep 1;2012:707586. doi: 10.5402/2012/707586. eCollection 2012.
2
Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.雌激素受体-α和转染后重排酪氨酸激酶的下调与 Withaferin A 诱导 MCF-7 乳腺癌细胞凋亡有关。
BMC Complement Altern Med. 2011 Oct 6;11:84. doi: 10.1186/1472-6882-11-84.
3
Proteasome inhibitor MG132 induces BAG3 expression through activation of heat shock factor 1.蛋白酶体抑制剂MG132通过激活热休克因子1诱导BAG3表达。
J Cell Physiol. 2009 Mar;218(3):631-7. doi: 10.1002/jcp.21634.
4
Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.甾体生物碱 4β-羟基茄次碱 E 和澳洲茄次碱 A 对人乳腺癌细胞 Akt 信号通路的不同影响。
Phytomedicine. 2019 Feb;53:213-222. doi: 10.1016/j.phymed.2018.09.017. Epub 2018 Sep 5.
5
Proteasome inhibitors MG132 and lactacystin hyperphosphorylate HSF1 and induce hsp70 and hsp27 expression.蛋白酶体抑制剂MG132和乳胞素使HSF1发生过度磷酸化,并诱导hsp70和hsp27表达。
Biochem Biophys Res Commun. 1999 Jan 8;254(1):264-8. doi: 10.1006/bbrc.1998.9840.
6
Heat-induced proteasomic degradation of HSF1 in serum-starved human fibroblasts aging in vitro.热诱导血清饥饿的体外老化人成纤维细胞中HSF1的蛋白酶体降解。
Exp Cell Res. 2001 Jul 15;267(2):165-72. doi: 10.1006/excr.2001.5237.
7
The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".肿瘤蛋白酶体是从“印度冬樱”中分离出的天然抗癌化合物Withaferin A的主要作用靶点。
Mol Pharmacol. 2007 Feb;71(2):426-37. doi: 10.1124/mol.106.030015. Epub 2006 Nov 8.
8
Withaferin A Induces ROS-Mediated Paraptosis in Human Breast Cancer Cell-Lines MCF-7 and MDA-MB-231.睡茄内酯A诱导人乳腺癌细胞系MCF-7和MDA-MB-231中活性氧介导的副凋亡。
PLoS One. 2016 Dec 29;11(12):e0168488. doi: 10.1371/journal.pone.0168488. eCollection 2016.
9
NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.NZ28诱导的HSF1、SP1和NF-κB抑制引发人肿瘤细胞上自然杀伤细胞激活配体MICA/B的丧失。
Cancer Immunol Immunother. 2015 May;64(5):599-608. doi: 10.1007/s00262-015-1665-9. Epub 2015 Feb 18.
10
A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers.一种新型的 withaferin A 和索拉非尼联合用药对甲状腺乳头状癌和间变性甲状腺癌均具有协同疗效。
Am J Surg. 2012 Dec;204(6):895-900; discussion 900-1. doi: 10.1016/j.amjsurg.2012.07.027.

引用本文的文献

1
Mechanisms and potential therapeutic strategies of withaferin A in breast cancer.Withaferin A在乳腺癌中的作用机制及潜在治疗策略
Pharmacol Rep. 2025 May 20. doi: 10.1007/s43440-025-00736-3.
2
Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms.醉茄素 A:一种有前景的膳食补充剂,有望成为癌症治疗的抗肿瘤治疗药物 - 药理学和机制。
Drug Des Devel Ther. 2023 Sep 21;17:2909-2929. doi: 10.2147/DDDT.S422512. eCollection 2023.
3
Disruption of Proteostasis by Natural Products and Synthetic Compounds That Induce Pervasive Unfolding of Proteins: Therapeutic Implications.

本文引用的文献

1
Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR.热休克转录因子 Hsf1 通过调节缺氧诱导因子 1 和 RNA 结合蛋白 HuR 参与肿瘤进展。
Mol Cell Biol. 2012 Mar;32(5):929-40. doi: 10.1128/MCB.05921-11. Epub 2012 Jan 3.
2
Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A.天然甾体 Withaferin A 抑制卵巢癌细胞系 CaOV3 和 SKOV3 的细胞生长并诱导细胞凋亡。
Gynecol Oncol. 2012 Mar;124(3):606-12. doi: 10.1016/j.ygyno.2011.11.044. Epub 2011 Dec 3.
3
天然产物和合成化合物对蛋白质稳态的破坏:诱导蛋白质广泛展开的作用及其治疗意义
Pharmaceuticals (Basel). 2023 Apr 19;16(4):616. doi: 10.3390/ph16040616.
4
Withaferin A suppresses skin tumor promotion by inhibiting proteasome-dependent isocitrate dehydrogenase 1 degradation.Withaferin A通过抑制蛋白酶体依赖性异柠檬酸脱氢酶1的降解来抑制皮肤肿瘤的促进作用。
Transl Cancer Res. 2019 Oct;8(6):2449-2460. doi: 10.21037/tcr.2019.09.57.
5
A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.白藜芦醇 A 抑制乳腺癌作用机制的全面综述与展望
Cancer Prev Res (Phila). 2020 Sep;13(9):721-734. doi: 10.1158/1940-6207.CAPR-20-0259. Epub 2020 Jul 29.
6
Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer.模拟 HDL 纳米颗粒:一种针对三阴性乳腺癌的新型药物递送策略。
Surgery. 2019 Dec;166(6):1168-1175. doi: 10.1016/j.surg.2019.06.010. Epub 2019 Jul 29.
7
Natural Withanolides in the Treatment of Chronic Diseases.天然睡茄内酯类化合物在慢性病治疗中的应用
Adv Exp Med Biol. 2016;928:329-373. doi: 10.1007/978-3-319-41334-1_14.
8
Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of Action.Withaferin-A——一种具有多效作用机制的天然抗癌剂。
Int J Mol Sci. 2016 Mar 4;17(3):290. doi: 10.3390/ijms17030290.
9
Pleiotropic role of HSF1 in neoplastic transformation.HSF1在肿瘤转化中的多效性作用。
Curr Cancer Drug Targets. 2014;14(2):144-55. doi: 10.2174/1568009614666140122155942.
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer.
高水平的核热休克因子 1(HSF1)与乳腺癌的不良预后相关。
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18378-83. doi: 10.1073/pnas.1115031108. Epub 2011 Oct 31.
4
Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.雌激素受体-α和转染后重排酪氨酸激酶的下调与 Withaferin A 诱导 MCF-7 乳腺癌细胞凋亡有关。
BMC Complement Altern Med. 2011 Oct 6;11:84. doi: 10.1186/1472-6882-11-84.
5
Triple-negative breast cancer: current state of the art.三阴性乳腺癌:当前的技术水平
Tumori. 2010 Nov-Dec;96(6):875-88.
6
Turnover of BRCA1 involves in radiation-induced apoptosis.BRCA1 的周转率涉及辐射诱导的细胞凋亡。
PLoS One. 2010 Dec 31;5(12):e14484. doi: 10.1371/journal.pone.0014484.
7
Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.铁皮石斛酚 A 抑制人乳腺癌细胞中转录激活子 3 的激活。
Carcinogenesis. 2010 Nov;31(11):1991-8. doi: 10.1093/carcin/bgq175. Epub 2010 Aug 19.
8
Heat shock proteins in breast cancer progression--a suitable case for treatment?热休克蛋白在乳腺癌进展中的作用——治疗的合适靶点?
Int J Hyperthermia. 2010;26(7):681-5. doi: 10.3109/02656736.2010.490254.
9
Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis.热休克转录因子 HSF1 在人类表皮生长因子受体 2 诱导的细胞转化和肿瘤发生中具有关键作用。
Oncogene. 2010 Sep 16;29(37):5204-13. doi: 10.1038/onc.2010.277. Epub 2010 Jul 12.
10
BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications.BRCA1 16 年后:与风险相关的 BRCA1 突变及其功能意义。
FEBS J. 2010 Aug;277(15):3086-96. doi: 10.1111/j.1742-4658.2010.07735.x. Epub 2010 Jul 1.